ROCHESTER, N.Y., Oct. 5 (HSMN NewsFeed) — Bausch & Lomb, the global eye health company, today announced it has acquired the commercial assets of Tubilux Pharma S.p.A. Tubilux is a privately held ophthalmic pharmaceuticals company that develops and ma…
Biopharmaceuticals, Ophthalmology, Acquisitions
Bausch & Lomb

If you are a sales professional or want to become one, or if you are looking for a new sales job, you will face one of the toughest interview processes of any job seeker.
0 Comments on “Bausch and Lomb Acquires the Commercial Assets of Italian Ophthalmic Pharmaceuticals Company Tubilux”
Leave a Comment